Co-Authors
This is a "connection" page, showing publications co-authored by Erin Michos and Khurram Nasir.
Connection Strength
1.444
-
Association of Depression Risk with Patient Experience, Healthcare Expenditure, and Health Resource Utilization Among Adults with Atherosclerotic Cardiovascular Disease. J Gen Intern Med. 2019 11; 34(11):2427-2434.
Score: 0.210
-
Alcohol and ideal cardiovascular health: The Multi-Ethnic Study of Atherosclerosis. Clin Cardiol. 2019 Jan; 42(1):151-158.
Score: 0.200
-
Life's Simple 7 and the risk of atrial fibrillation: The Multi-Ethnic Study of Atherosclerosis. Atherosclerosis. 2018 08; 275:174-181.
Score: 0.193
-
Psychological Factors and Their Association with Ideal Cardiovascular Health Among Women and Men. J Womens Health (Larchmt). 2018 05; 27(5):709-715.
Score: 0.188
-
Does education modify the effect of ethnicity in the expression of ideal cardiovascular health? The Baptist Health South Florida Employee Study. Clin Cardiol. 2017 Nov; 40(11):1000-1007.
Score: 0.181
-
Life's Simple 7 and Incident Heart Failure: The Multi-Ethnic Study of Atherosclerosis. J Am Heart Assoc. 2017 Jun 27; 6(6).
Score: 0.181
-
Association of Coronary Artery Calcium With Long-term, Cause-Specific Mortality Among Young Adults. JAMA Netw Open. 2019 07 03; 2(7):e197440.
Score: 0.052
-
Breast Arterial Calcium: A Game Changer in Women's Cardiovascular Health? JACC Cardiovasc Imaging. 2019 12; 12(12):2538-2548.
Score: 0.051
-
Applicability and Cost Implications for Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors Based on the ODYSSEY Outcomes Trial. Circulation. 2019 01 15; 139(3):410-412.
Score: 0.050
-
Statin prescription rates and their facility-level variation in patients with peripheral artery disease and ischemic cerebrovascular disease: Insights from the Department of Veterans Affairs. Vasc Med. 2018 06; 23(3):232-240.
Score: 0.048
-
A systematic review of the associations between HIV/HCV coinfection and biomarkers of cardiovascular disease. Rev Med Virol. 2018 Jan; 28(1).
Score: 0.046
-
Estimation of Eligibility for Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors and Associated Costs Based on the FOURIER Trial (Further Cardiovascular Outcomes Research With PCSK9 Inhibition in Subjects With Elevated Risk): Insights From the Department of Veterans Affairs. Circulation. 2017 06 20; 135(25):2572-2574.
Score: 0.045